Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Regulatory News (TILS)

  • There is currently no data for TILS

PRG Nutraceuticals UK Launch

1 Oct 2009 10:34

RNS Number : 0408A
ReGen Therapeutics PLC
01 October 2009
 



1 October 2009

For immediate release

ReGen Announces PRG Nutraceuticals Limited UK Launch

ReGen Therapeutics Plc ('ReGen' or the 'Company') is pleased to announce that it has been notified by PRG Nutraceuticals Limited that it has launched Colostrinin™* as 'MemoryAid' in the UK.

Announcing the launch, PRG Managing Director Dr Peter Garrod said:-

"Every day we hear more evidence of how the population faces a terrible future as our brains become increasingly affected by conditions associated with getting old. MemoryAid contains a complex that we believe will help people to fight the onset of the problems that result from our brains undergoing the normal ageing process. Many years of research into the complex has shown that it promotes antioxidant activity, can reduce the toxicity of beta amyloid and protects the brain against the damaging effects of free radicals, all of which manifest themselves in the problems that occur as our brains naturally age. The complex has also been shown to increase the average lifespan of living cells and reduces premature ageing, which will also benefit consumers.

MemoryAid is targeted at a wide spectrum of people, both the older community, who may already be noticing that their brains are not functioning in the manner they are normally accustomed to, and at younger adults, who just want to protect themselves against memory deterioration in the future.

We are very excited by the benefits of MemoryAid and believe that it has a bright future on everyone's breakfast table."

MemoryAid is available on the internet at www.memoryaid.com or by contacting PRG on 01580 891349 or mobile 07785 740421.  

MemoryAid

Support for healthy brain ageing

Maintains normal mental function and supports healthy brain ageing.

Increases the average lifespan of living cells.

Reduces the aggregation and toxicity of beta amyloid, a feature of neurodegenerative conditions.

Protects the brain against the damaging effects of many free radicals

*Colostrinin™ is a proline-rich polypeptide complex that maintains normal mental function and supports healthy brain ageing.

For further information:

Dr Peter Garrod

PRG Nutraceuticals Ltd

Tel. 01580 891349 / 07785 740421

Percy Lomax ReGen Therapeutics Plc Tel No 020 7153 4920

Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel No 020 7628 3396

Nick Bealer/David Scott Alexander David Tel No 020 7448 9820 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGCBDGIDGGGCB
Date   Source Headline
24th Nov 20157:00 amRNSAppointment of Non-Executive Director
30th Oct 20157:00 amRNSExercise of Warrants & Issue of Equity
30th Sep 20157:00 amRNSHalf Yearly Report
30th Jun 201512:48 pmRNSResult of AGM
5th Jun 20157:00 amRNSFinal Results and Notice of AGM
7th May 20154:40 pmRNSSecond Price Monitoring Extn
7th May 20154:35 pmRNSPrice Monitoring Extension
7th May 20157:10 amRNSDirectorate Change
7th May 20157:05 amRNSElection to U.S. National Academy of Sciences
7th May 20157:00 amRNSLicences new anti-cancer stem cell technology
21st Apr 20157:00 amRNSIssue of convertible loan notes and warrants
31st Mar 20157:00 amRNSPlacing to raise £2.55 million
20th Mar 20157:00 amRNSExercise of Options and Issue of Equity
3rd Mar 20157:00 amRNSGrant of Options
26th Jan 20157:00 amRNSGrant of Options
23rd Jan 20152:04 pmRNSBoard changes
20th Jan 20157:00 amRNSLicenses milciclib from Nerviano Medical Sciences
22nd Dec 20147:00 amRNSRe Agreement with Novimmune
31st Mar 20149:00 amRNSSchedule 1 - Alexander David Investments plc
31st Mar 20147:31 amRNSRestoration - Alexander David Investments plc
19th Dec 20133:00 pmRNSSuspension - Alexander David Investments Plc
30th Aug 20137:30 amRNSRestoration - Alexander David Investments plc
19th Apr 20137:30 amRNSSuspension - Alexander David Investments Plc
1st May 20124:25 pmRNSReplacement: Holding(s) in Company
30th Apr 20122:46 pmRNSHolding(s) in Company
2nd Apr 20123:32 pmRNSHolding(s) in Company
12th Mar 20122:45 pmRNSHolding(s) in Company
17th Dec 200910:13 amRNSUSA Sales Update
1st Oct 200910:34 amRNSPRG Nutraceuticals UK Launch
1st Jul 20095:10 pmRNSHolding(s) in Company
30th Jun 20095:41 pmRNSHolding(s) in Company
30th Jun 20092:27 pmRNSAudited Accounts, Notice of AGM & TVR
23rd Jun 20097:00 amRNSIssue of Equity
17th Jun 20093:49 pmRNSHolding(s) in Company
16th Jun 20094:15 pmRNSPreliminary Results
15th Jun 20095:06 pmRNSHolding(s) in Company
12th Jun 200912:05 pmRNSIssue of Equity
10th Jun 20093:39 pmRNSShareholding
4th Jun 20097:00 amRNSIssue of Equity
2nd Jun 20092:52 pmRNSHolding(s) in Company
2nd Jun 200912:50 pmRNSColostrinin Distribution in Poland
20th May 20095:28 pmRNSShareholding
5th May 20094:50 pmRNSHolding(s) in Company
5th May 200912:56 pmRNSShareholding in Company
30th Apr 20092:08 pmRNSTotal Voting Rights
28th Apr 20094:24 pmRNSHolding(s) in Company
24th Apr 20094:35 pmRNSIssue of Equity
22nd Apr 200912:10 pmRNSHolding(s) in Company
17th Apr 20093:47 pmRNSShareholding
15th Apr 20097:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.